NUVAMA - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.9
| Stock Code | NUVAMA | Market Cap | 24,148 Cr. | Current Price | 1,326 ₹ | High / Low | 1,702 ₹ |
| Stock P/E | 42.0 | Book Value | 109 ₹ | Dividend Yield | 2.18 % | ROCE | 30.6 % |
| ROE | 32.6 % | Face Value | 2.00 ₹ | DMA 50 | 1,295 ₹ | DMA 200 | 1,329 ₹ |
| Chg in FII Hold | 0.55 % | Chg in DII Hold | -0.07 % | PAT Qtr | 280 Cr. | PAT Prev Qtr | 46.4 Cr. |
| RSI | 53.5 | MACD | 34.8 | Volume | 3,68,097 | Avg Vol 1Wk | 3,17,544 |
| Low price | 1,097 ₹ | High price | 1,702 ₹ | PEG Ratio | 0.29 | Debt to equity | 0.19 |
| 52w Index | 37.9 % | Qtr Profit Var | 35.5 % | EPS | 31.8 ₹ | Industry PE | 18.5 |
📊 Financials: NUVAMA demonstrates strong fundamentals with ROE at 32.6% and ROCE at 30.6%. EPS is ₹31.8, supported by quarterly PAT growth (₹280 Cr vs ₹46.4 Cr). Debt-to-equity ratio of 0.19 reflects low leverage, enhancing financial stability. Dividend yield of 2.18% provides steady income support.
💹 Valuation: The stock trades at a P/E of 42.0, significantly above the industry average of 18.5, suggesting stretched valuation. However, PEG ratio of 0.29 highlights attractive growth-adjusted pricing. Book value of ₹109 provides intrinsic support. Overall, valuation is expensive but justified by strong growth momentum.
🏭 Business Model: NUVAMA operates in financial services, with strengths in diversified offerings, efficiency, and institutional presence. Its competitive advantage lies in strong profitability, dividend payouts, and growth visibility. However, high valuations and reduced DII holdings limit near-term attractiveness.
📈 Entry Zone: Attractive entry would be near ₹1,250–₹1,280, aligning with support levels and fairer valuation. Current price (₹1,326) is near both 50 DMA (₹1,295) and 200 DMA (₹1,329), suggesting consolidation. Long-term investors may accumulate gradually, focusing on sustained ROE and earnings growth.
Positive
- Strong ROE (32.6%) and ROCE (30.6%).
- Low debt-to-equity ratio (0.19).
- Dividend yield of 2.18% provides steady returns.
- FII holdings increased (+0.55%), showing foreign investor confidence.
Limitation
- High P/E (42.0) vs industry average (18.5).
- DII holdings declined (-0.07%), showing reduced domestic support.
- Stock trading near highs, limiting immediate upside.
Company Negative News
- Valuation concerns due to high P/E.
- Decline in DII holdings (-0.07%).
Company Positive News
- Quarterly PAT surged to ₹280 Cr.
- FII inflows (+0.55%) reflect strong foreign confidence.
- Strong efficiency metrics and dividend payouts.
Industry
- Financial services sector remains resilient with growth opportunities.
- Industry P/E at 18.5 highlights NUVAMA’s premium valuation.
- Sector growth supported by rising financial participation and institutional demand.
Conclusion
⚖️ NUVAMA demonstrates strong efficiency, profitability, and dividend support but trades at stretched valuations. Entry is favorable near ₹1,250–₹1,280 for long-term investors. Current levels suggest cautious accumulation, with better opportunities on dips. Holding is recommended for long-term growth, provided ROE sustains above 30% and earnings momentum continues.